Does AMINOLEVULINIC ACID Cause Product packaging quantity issue? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Product packaging quantity issue have been filed in association with AMINOLEVULINIC ACID (AMELUZ). This represents 0.9% of all adverse event reports for AMINOLEVULINIC ACID.
14
Reports of Product packaging quantity issue with AMINOLEVULINIC ACID
0.9%
of all AMINOLEVULINIC ACID reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From AMINOLEVULINIC ACID?
Of the 14 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMINOLEVULINIC ACID. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does AMINOLEVULINIC ACID Cause?
Drug ineffective (293)
Off label use (178)
Wrong technique in product usage process (173)
Erythema (144)
Product quality issue (132)
Poor quality product administered (124)
Pain (102)
Product dose omission issue (93)
Application site pain (90)
Application site erythema (81)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which AMINOLEVULINIC ACID Alternatives Have Lower Product packaging quantity issue Risk?
AMINOLEVULINIC ACID vs AMINOPHYLLINE
AMINOLEVULINIC ACID vs AMINOSALICYLATE
AMINOLEVULINIC ACID vs AMINOSALICYLIC ACID
AMINOLEVULINIC ACID vs AMIODARONE
AMINOLEVULINIC ACID vs AMISULPRIDE